Abbott Laboratories
Pharmaceutical & Health Products · Lobbying Client
Abbott Laboratories's Federal Lobbying Record
At $23.3M in disclosed federal lobbying, Abbott Laboratories ranks as a major spender — well above the typical filer. Outlays in this range generally reflect a sustained presence in Washington, with at least one full-time government affairs lead and a stable of outside lobbyists engaged on the organization's priority issues.
Across the 5-year window from 2020 to 2024, Abbott Laboratories's annual disclosed lobbying spend has declined modestly — from $4.7M in 2020 to $4.3M in 2024, a change of -8%. Step-changes of this size often coincide with major bills moving through Congress, regulatory rulemakings affecting the organization's industry, or a leadership change in the relevant committee.
Abbott Laboratories's disclosed lobbying covers 6 general issue areas — a moderate footprint. Filers in this range tend to engage on a coherent cluster of related topics rather than spreading effort across the federal agenda.
6 of 16 lobbyists reported by Abbott Laboratories (38%) disclose prior federal government service. That share is common at established government affairs operations that explicitly hire from agency and committee staff.
Among the named bench, lobbyists with disclosed prior federal service include Kimberly H. Campbell (Former Legislative Director, U.S. House of Representatives); Ashley C. Turner (Former Senior Advisor, White House); Steven F. Martin (Former Deputy Administrator, EPA). The covered-position field on LDA cover sheets captures executive-branch and senior congressional roles held within the prior two years.
Within the Pharmaceutical & Health Products sector, Abbott Laboratories ranks #6 of 34 tracked organizations by disclosed lobbying spend. The sector leader is Pharmaceutical Research & Manufacturers of America at $135.8M; the sector average is $16.7M. Abbott Laboratories's $23.3M sits 39% above the sector average.
Abbott Laboratories's LobbySpend Influence Score of 63/100 (grade B) reflects significant federal lobbying reach. The score blends disclosed total spend, issue breadth, and revolving-door connections — lobbyists with prior federal government service. A B-grade typically means the organization is well above average on at least two of those three signals, with sustained activity over multiple years rather than a one-off spike.
Every figure above is sourced from Senate lobbying disclosure filings submitted under the Lobbying Disclosure Act of 1995. Per-issue dollar splits and covered-position flags are filer-reported and may be amended after initial submission.
Track Abbott Laboratories's lobbying filings
Subscribe for LobbySpend updates by email. No spam, unsubscribe anytime.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2024 Oct-Dec | Stewart & Stewart | TAXGOV | 3 | $1.2M |
| 2024 Jul-Sep | Williams & Jensen | TAXPHAHCR+2 | 2 | $1.2M |
| 2024 Apr-Jun | Capitol Counsel | MEDHCRPHA | 2 | $1.1M |
| 2024 Jan-Mar | Cornerstone Government Affairs | MEDTAX | 4 | $915K |
| 2023 Oct-Dec | DLA Piper | PHATAXGOV+2 | 2 | $1.4M |
| 2023 Jul-Sep | Van Scoyoc Associates | MEDGOVTAX+1 | 4 | $1.2M |
| 2023 Apr-Jun | Covington & Burling | MEDHCR | 4 | $1.2M |
| 2023 Jan-Mar | Hogan Lovells | HCRMED | 3 | $1.3M |
Abbott Laboratories Lobbying FAQ
Abbott Laboratories has spent $23.3M on federal lobbying across 6 policy areas. This includes spending on registered lobbyists and direct government contacts.
Abbott Laboratories lobbies on 6 policy issues, including Health Issues, Medical/Disease Research, Pharmacy, Taxation. These disclosures are filed quarterly with the Senate Office of Public Records.
Abbott Laboratories has an Influence Score of 63/100 (Grade B). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).
Abbott Laboratories employs 16 registered lobbyists, of whom 6 have revolving door connections, meaning they previously held government positions before becoming lobbyists.
Abbott Laboratories has contacted 8 government entities as part of their lobbying activities, including Small Business Administration, Dept of Energy, Dept of Homeland Security.
Explore Other Lobbying Organizations
$387.8M lobbying spend · Trade Association · Influence Score B
$348.2M lobbying spend · Real Estate · Influence Score B
$135.8M lobbying spend · Pharmaceutical & Health Products · Influence Score B
$128.0M lobbying spend · Healthcare · Influence Score B
Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.